Preliminary investigations of the suitability of the USP uniformity of dosage units tests for evaluating the uniformity of powder blends and their corresponding tablets

M. Murray,A. Sakr,S. Uraizee

Abstract:The influences of mixing time, manufacturing stage, and sample size on the evaluation of content uniformity in low dose direct compression blends and their corresponding tablets were studied. A high speed stationary shell mixer was used to blend 16 l-kg batches of a direct compression low dose formulation containing 0.1% theophylline, 99.4% microcrystalline cellulose (Avice® PH-200), and 0.5% magnesium stearate. Batches were mixed for 1 or 60 min. Numerous powder samples and compressed tablets were tested for USP XXII Uniformity of Dosage Units. From each batch, 100 dose units divided into 10 groups of 10 were individually assayed. At 1-min mixing the mean percent label claim of the tablets was significantly different from the powder samples (p≤0.0001). For the tablets the percent label claim ranged from 58-350% and the % relative standard deviations (RSDs) ranged from 3-79%. However, the percent label claim of the powder samples ranged from 31-113%, with % RSDs ranging from 4-54%. At the 60-min mixing time the difference between the mean % label content of the tablets and powder samples was also significant (p≤0.0001). For tablets, percent label claim ranged between 40 and 113%, with % RSDs ranging from 17-36%, while for the powders, the percent label claim ranged from 8-563% and the % RSD range was 24-119%. A maximum 3.75% relative standard deviation of tablet weight was found among the 90 groups assayed. Although the results were outside the USP test acceptable limits, the content uniformity of the tablets was significantly different to that of powder samples at both mixing times. The results indicate that the content uniformity of powder samples collected prior to tabletting is not a suitable indicator of the finished product content uniformity. The results of the content uniformity statistical analysis suggUSP test may be inadequate. There is an urgent need to re-evaluate USP test for Uniformity of Dosage Units in relationship to the percent drug content in the tablet and the therapeutic index of the drug

Chemistry,Medicine